Gpvds Pharmedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-11-2024
- Paid Up Capital ₹ 0.20 M
as on 07-11-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
as on 07-11-2024
- Revenue 168.98%
(FY 2023)
- Profit 252.09%
(FY 2023)
- Ebitda 220.36%
(FY 2023)
- Net Worth 327.05%
(FY 2023)
- Total Assets 121.26%
(FY 2023)
About Gpvds Pharmedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹9.00 Cr.
Vibhor Singhania, Sukanta Bhattacharya, and Deepak Chauhan serve as directors at the Company.
- CIN/LLPIN
U51397UP2021PTC145894
- Company No.
145894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gpvds Pharmedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vibhor Singhania  | Director | 05-May-2021 | Current |
| Sukanta Bhattacharya | Director | 10-Mar-2023 | Current |
| Deepak Chauhan | Director | 10-Mar-2023 | Current |
Financial Performance of Gpvds Pharmedies.
Gpvds Pharmedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 168.98% increase. The company also saw a substantial improvement in profitability, with a 252.09% increase in profit. The company's net worth Soared by an impressive increase of 327.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gpvds Pharmedies?
In 2023, Gpvds Pharmedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2022 | ₹9.00 Cr | Open |
How Many Employees Work at Gpvds Pharmedies?
Unlock and access historical data on people associated with Gpvds Pharmedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gpvds Pharmedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gpvds Pharmedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
